South Piedmont AHEC

Charlotte Hematologic Malignancies Congress 2026

Share This Event

Charlotte Hematologic Malignancies Congress 2026 image

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Description

This congress will provide an overview of the most recent clinical updates and translational research in myeloid malignancies, lymphoid malignancies, and plasma cell disorders. The program will review the recent approvals in these areas and their implications in treatment planning and management of patient care.

The congress is specifically designed to address common questions community oncologists face including: implementation of T-cell redirecting therapies, infection prevention, and mitigation of adverse events after CAR-T and/or bispecific antibody therapy. Coordination of care between community oncologists and tertiary care centers will be a significant theme of the congress to ensure applicability to all parties.

For a FULL AGENDA and DETAILS: Charlotte Hematologic Malignancies Congress 2026 AGENDA & FACULTY.

Register

Accreditation Statement
JA
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement(s)
American Medical Association (AMA)
Advocate Health designates this live activity for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Advocate Health designates this live activity for a maximum of 8.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Physician Associates (AAPA)
Advocate Health has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Accreditation Council for Pharmacy Education (ACPE)
Advocate Health designates this live activity for a maximum 8.50 hours of CPE credit for (pharmacists and pharmacy technicians). CPE credit can be claimed on the AAH CE platform within 60 days of activity completion and information will be provided to CPE Monitor. Participants should only claim credit commensurate with the extent of their participation in the activity.
Pharmacy UAN: JA0006327-0000-26-117-L01-P

Board Recognition Statement(s)
American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

ADA Statement
If you need any auxiliary aids or services identified in the Americans with Disabilities Act in order to attend this conference, please contact Gina Barnard by email gina.barnard@advocatehealth.org.

Webinar information & Test Page
The webinar will be broadcast with Zoom. Instructions to join the Live Webinar will be emailed prior to the event. You can test your computer by going to the Zoom Test Page.

Register

* Registering for and attending a South Piedmont AHEC program authorizes South Piedmont AHEC to take audio, video, and/or still images to be used for promotional and educational purposes. If you have concerns, please speak with a South Piedmont AHEC team member.

Objectives

  • Integrate novel and newly approved therapies for hematologic malignancies into evidence-based treatment plans.
  • Apply appropriate patient selection criteria and sequencing strategies for novel therapies.
  • Identify and manage therapy related toxicities, using evidence-based prevention and mitigation strategies.
  • Implement coordinated care models between community oncologists and tertiary care centers.
  • Evaluate emerging translational research and investigational therapies in hematologic malignancies.

Sessions

Status
Open
Presenter(s)
Tamara Moyo MD, PhD, Barry Paul MD, MS, Cindy Varga MD, Amer Zeidan , Joshua Zeidner MD
Date(s)
Oct 23 - 24, 2026
Check-In Time
1:00 PM
Credit
8.50 - AMA PRA Category 1 Credit™
8.50 - ACPE
8.50 - Nursing Contact Hours
8.50 - American Board of Surgery - Accredited CME
Location
Omni Charlotte Hotel

78179Open Charlotte Hematologic Malignancies Congress 2026 image


Oct 23 - 24, 2026
Omni Charlotte Hotel
Gina Barnard BA
704-512-6523

Fees


$300.00
Industry registration fee Industry is defined here as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical
$0.00
Practicing healthcare providers registration fee

Credits


8.50
AMA PRA Category 1 Credit™
8.50
ACPE
8.50
Nursing Contact Hours
8.50
American Board of Surgery - Accredited CME